Drugmakers Hope New Heart Drugs Boost Sales, Revive Market

  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 53%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

A wave of new drugs to treat heart diseases is starting to reach patients, as drugmakers work to revive a $48 billion category that once powered the industry

The once lucrative heart-drug market is now poised to make a comeback, but at the cost of heavy investments in research and deal making.

After watching lower-priced generics seize sales of once-highflying blood-pressure, cholesterol and other heart drugs, companies struggled to discover replacements and then win reimbursement for five-figure prices. Drugmakers are now rolling out new medicines, though their commercial prospects are uncertain.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 413. in SE

Sverige Senaste nytt, Sverige Rubriker